PMC full text:
Published online 2024 Oct 3. doi: 10.5144/0256-4947.2024.306
Table 3.
Variant and vaccinated patient data of COVID-19 PCR positive cesarean section patients.
| Variants | Delta (n=5) | Omicron (n=1) | English (n=1) |
|---|---|---|---|
| Age | 32.4 (5.22) | 39 | 37 |
| Gravidity | 3.0 (1.5-5.0) | 4 | 3 |
| Parity | 2.0 (0.5-4.0) | 3 | 2 |
| Gestational week | 34.8 (4.71) | 37 | 35 |
| APGAR 1’ score | 8.0 (2.5-8.0) | 8 | 7 |
| APGAR 5’ score | 9.0 (6.5-9.0) | 9 | 8 |
| Indication placental anomaly | 0 | 0 | 0 |
| Indication presentation anomaly/CPD | 0 | 0 | 0 |
| Indication fetal distress | 1 | 0 | 0 |
| Indication maternal ARDS | 2 | 1 | 0 |
| Indication previous uterine surgery | 2 | 0 | 1 |
| Additional chronic disease malignancy | 0 | 0 | 0 |
| Additional chronic thyroid disease | 0 | 0 | 0 |
| Additional chronic diabetes | 0 | 0 | 0 |
| Additional chronic respiratory disorder | 0 | 0 | 0 |
| Additional chronic hypertensive disorder | 0 | 0 | 0 |
| Vaccinated patient | 0 | 0 | 0 |
| ICU administration | 4 (80) | 1 (100) | 0 |
| Mortality | 2 (40) | 0 | 0 |
| Vaccinated patients | Biontech (1 dose) (n=1) | Biontech (2 doses) (n=7) | Biontech (3 doses) (n=1) | Sinovac (2 doses) (n=3) |
|---|---|---|---|---|
| Age | 40 | 30.8 (5.27) | 29 | 31.6 (5.03) |
| Gravidity | 3 | 2.0 (2.0-3.0) | 1 | 2.0 (2.0-2.0) |
| Parity | 2 | 1.0 (1.0-2.0) | 0 | 1.0 (1.0-1.0) |
| Gestational week | 32 | 37.5 (1.68) | 27 | 37.0 (1.0) |
| APGAR 1’ score | 6 | 7.0 (7.0-8.0) | 4 | 8.0 (8.0-9.0) |
| APGAR 5’ score | 8 | 9.0 (8.0-9.0) | 7 | 9.0 (9.0-9.0) |
| Indication placental anomaly | 0 | 0 | 1 | 0 |
| Indication presentation anomaly/CPD | 0 | 2 | 0 | 0 |
| Indication fetal distress | 0 | 0 | 0 | 0 |
| Indication maternal ARDS | 0 | 0 | 0 | 0 |
| Indication previous uterine surgery | 1 | 5 | 0 | 3 |
| Additional chronic disease malignancy | 0 | 0 | 0 | 0 |
| Additional chronic thyroid disease | 0 | 1 | 0 | 0 |
| Additional chronic diabetes | 0 | 0 | 0 | 0 |
| Additional chronic respiratory disorder | 0 | 2 | 0 | 0 |
| Additional chronic hypertensive disorder | 0 | 0 | 0 | 0 |
| Variant | 0 | 0 | 0 | 0 |
| ICU administration | 0 | 0 | 0 | 0 |
| Mortality | 0 | 0 | 0 | 0 |
Results were presented as mean (SD) for normally distributed data, median (25-75 percentile) was used for non-normally distributed data, and number (percentage) for categorical variables. To compare independent categorical variables, the chi-square test was applied, and the results were reported as numbers and percentages. CPD: Cephalo-pelvic disproportion; ARDS: acute respiratory distress syndrome; ICU: Intensive care unit.